Our preliminary results, obtained in a single-institution study with limited enrolment, showed that the hypermethylation of GSTP1, RARB, RASSF1, SCGB3A1 and CCND2 was highly tumour-specific in prostate cancer tissue. Here, CCND2 is linked to prostate carcinoma.